It isgenerally accepted that excessive production and/or activation of TGF-β by tumor cells promotescancer progression by mechanisms that include increased tumor neoangiogenesis, extracellular matrixproduction, upregulation of proteases, and inhibition of immune surveillance in the cancer host[24], [25]. This evidence concerns the gene TGFB1 and neoplasm.